Successful Medical Camp with Senior Liver Transplant Surgeon in Uzbekistan
Date
12/10/2024 2:17:00 AM
(MENAFN- Vaidam Health) In a significant effort to enhance healthcare access in Uzbekistan, a medical camp hosted by Vaidam health on November 27th and 28th, 2024, at the Regional Infectious disease Hospital in Samarkand achieved remarkable success.
This event provided specialized medical consultations to over 50 patients, led by Dr. Shailendra Lalwani, a renowned Liver Transplant Surgeon from Shalby Hospital, Delhi, India.
Dr. Lalwani, celebrated for his expertise in living donor liver transplants and advanced gastrointestinal treatments, addressed complex cases involving liver failure, cirrhosis, fatty liver, fibrosis, and abdominal cancers.
His presence offered new hope to many patients and their families while also setting the stage for collaborative learning with local medical professionals.
The partnership between the Regional Infectious Disease Hospital and Vaidam Health reflects a shared commitment to better healthcare and global collaboration.
About Vaidam Health
As a leading global medical assistance provider, Vaidam Health has supported over 100,000 patients from 125 countries. Having organized 200+ medical camps across 20+ countries, Vaidam connects patients to top specialists and hospitals worldwide for treatments such as cancer care, organ transplants, heart surgeries, and spine procedures.
We extend heartfelt gratitude to the patients, local doctors, and medical professionals who made this event successful. Together, we aim to bridge global healthcare expertise and deliver outstanding solutions to patients across the world.
For details about upcoming medical events or inquiries, reach out to us at +91-99716 16131.
MENAFN10122024007850016800ID1108974926
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.